Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant

Overview

Journal Kidney Int Rep

Publisher Elsevier

Specialty Nephrology

Date 2017 Dec 23

PMID 29270531

Citations 8

Authors

Tatiana Prokaeva

Harun Akar

Brian Spencer

Andrea Havasi

Haili Cui

Carl J OHara

Olga Gursky

John Leszyk

Martin Steffen

Sabrina Browning

Allison Rosenberg

Lawreen H Connors

Affiliations

Soon will be listed here.

Citing Articles

Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification.

Aguilan J, Lim J, Racine-Brzostek S, Fischer J, Silvescu C, Cornett S Clin Proteomics. 2024; 21(1):47.

PMID: 38961380 PMC: 11223398. DOI: 10.1186/s12014-024-09500-w.

Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes.

Delrue C, Dendooven A, Vandendriessche A, Speeckaert R, De Bruyne S, Speeckaert M Int J Mol Sci. 2024; 25(11).

PMID: 38892061 PMC: 11172584. DOI: 10.3390/ijms25115875.

Identification of apolipoprotein E-derived amyloid within cholesterol granulomas of leopard geckos (Eublepharis macularius).

Ikeda M, Kondo H, Murakami T, Iwaide S, Itoh Y, Shibuya H Sci Rep. 2024; 14(1):13746.

PMID: 38877049 PMC: 11178906. DOI: 10.1038/s41598-024-64643-y.

Kidney Biopsy Corner: Amyloidosis.

Biederman L, Dasgupta A, Dreyfus D, Nadasdy T, Satoskar A, Brodsky S Glomerular Dis. 2023; 3(1):165-177.

PMID: 37901698 PMC: 10601942. DOI: 10.1159/000533195.

Familial Mediterranean Fever in Spain: Time Trend and Spatial Distribution of the Hospitalizations.

Gallego E, Arias-Merino G, Sanchez-Diaz G, Villaverde-Hueso A, Posada de la Paz M, Alonso-Ferreira V Int J Environ Res Public Health. 2023; 20(5).

PMID: 36901385 PMC: 10002354. DOI: 10.3390/ijerph20054374.

References

Das M, Gursky O . Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights. Adv Exp Med Biol. 2015; 855:175-211. PMC: 5610898. DOI: 10.1007/978-3-319-17344-3_8. View

Lackner K, Edge S, GREGG R, Hoeg J, BREWER Jr H . Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms. J Biol Chem. 1985; 260(2):703-6. View

Dasari S, Amin M, Kurtin P, Vrana J, Theis J, Grogg K . Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis. Kidney Int. 2016; 90(3):658-64. DOI: 10.1016/j.kint.2016.04.003. View

Benson M, Liepnieks J, Yazaki M, Yamashita T, Hamidi Asl K, Guenther B . A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene. Genomics. 2001; 72(3):272-7. DOI: 10.1006/geno.2000.6499. View

Magy N, Liepnieks J, Yazaki M, Kluve-Beckerman B, Benson M . Renal transplantation for apolipoprotein AII amyloidosis. Amyloid. 2004; 10(4):224-8. DOI: 10.3109/13506120309041739. View

Valleix S, Verona G, Jourde-Chiche N, Nedelec B, Mangione P, Bridoux F . D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile. Nat Commun. 2016; 7:10353. PMC: 4735822. DOI: 10.1038/ncomms10353. View

De Gracia R, Fernandez E, Rinon C, Selgas R, Garcia-Bustos J . Hereditary renal amyloidosis associated with a novel mutation in the apolipoprotein AII gene. QJM. 2006; 99(4):274. DOI: 10.1093/qjmed/hcl032. View

Hawkins P . Hereditary systemic amyloidosis with renal involvement. J Nephrol. 2003; 16(3):443-8. View

Nuvolone M, Merlini G . Systemic amyloidosis: novel therapies and role of biomarkers. Nephrol Dial Transplant. 2016; 32(5):770-780. DOI: 10.1093/ndt/gfw305. View

10.

Benson M . Ostertag revisited: the inherited systemic amyloidoses without neuropathy. Amyloid. 2005; 12(2):75-87. DOI: 10.1080/13506120500106925. View

11.

Nasr S, Dasari S, Hasadsri L, Theis J, Vrana J, Gertz M . Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII. J Am Soc Nephrol. 2016; 28(2):439-445. PMC: 5280007. DOI: 10.1681/ASN.2015111228. View

12.

Argiles A, Garcia Garcia M, Mourad G . Phagocytosis of dialysis-related amyloid deposits by macrophages. Nephrol Dial Transplant. 2002; 17(6):1136-8. DOI: 10.1093/ndt/17.6.1136. View

13.

Walsh I, Seno F, Tosatto S, Trovato A . PASTA 2.0: an improved server for protein aggregation prediction. Nucleic Acids Res. 2014; 42(Web Server issue):W301-7. PMC: 4086119. DOI: 10.1093/nar/gku399. View

14.

Sethi S, Theis J, Shiller S, Nast C, Harrison D, Rennke H . Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int. 2011; 81(2):201-6. DOI: 10.1038/ki.2011.316. View

15.

Gillmore J, Lachmann H, Rowczenio D, Gilbertson J, Zeng C, Liu Z . Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis. J Am Soc Nephrol. 2008; 20(2):444-51. PMC: 2637055. DOI: 10.1681/ASN.2008060614. View

16.

Hamodrakas S, Liappa C, Iconomidou V . Consensus prediction of amyloidogenic determinants in amyloid fibril-forming proteins. Int J Biol Macromol. 2007; 41(3):295-300. DOI: 10.1016/j.ijbiomac.2007.03.008. View

17.

Stangou A, Banner N, Hendry B, Rela M, Portmann B, Wendon J . Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood. 2009; 115(15):2998-3007. DOI: 10.1182/blood-2009-06-223792. View

18.

Kiuru-Enari S, Haltia M . Hereditary gelsolin amyloidosis. Handb Clin Neurol. 2013; 115:659-81. DOI: 10.1016/B978-0-444-52902-2.00039-4. View

19.

Gursky O . Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men. FEBS Lett. 2014; 588(6):845-50. PMC: 3979420. DOI: 10.1016/j.febslet.2014.01.066. View

20.

Yazaki M, Liepnieks J, Barats M, Cohen A, Benson M . Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int. 2003; 64(1):11-6. DOI: 10.1046/j.1523-1755.2003.00047.x. View